Objective: To investigate the effects of the combination of extracorporeal cardiopulmonary resuscitation and thrombolytic therapy on the recovery of vital organ function after prolonged cardiac arrest. Design: Laboratory investigation.
S udden cardiac arrest (CA) is responsible for one out of every five deaths in the United States (1) . Average survival rates are less than 20% for in-hospital CA (IHCA) (2) and less than 11% for out-of-hospital CA (OHCA) (3) (4) (5) . A major limiting factor is failure to achieve return of spontaneous circulation (ROSC), with rates of sustained ROSC around 50% for IHCA (2) and 30% for OHCA (6) . Extracorporeal cardiopulmonary resuscitation (ECPR) is emerging as a feasible resuscitative strategy for patients who fail conventional resuscitative efforts, with reported survival rates ranging from 4% to 33% in selected patients (7) (8) (9) (10) . However, ECPR alone often fails to reverse myocardial failure and severe neurologic damage when the interval from arrest onset to initiation of ECPR is prolonged (7, 9, (11) (12) (13) (14) . The main causes of death in nonsurvivors resuscitated with ECPR are hemodynamic instability, multiple organ failure, and irreversible brain injury (11, 15) . Therefore, additional therapeutic strategies (mechanical cardiopulmonary resuscitation [CPR] or intra-arrest cooling) aimed at improving recovery of vital organ function after prolonged ischemia are required if ECPR is to be widely adopted to extend the duration of CA after which favorable outcome can be achieved (16) .
In addition to ischemic injury, endothelial damage and intravascular coagulation may limit recovery of organ function after prolonged CA (17) (18) (19) (20) (21) (22) (23) . Intravascular coagulation during CA was initially described by Crowell in 1955 (24) . Fischer et al (25) demonstrated that IV thrombolytic therapy given during CPR reduces the brain no-reflow phenomenon in animals after prolonged CA. Recent studies of organ in vivo perfusion for donation after cardiac death (DCD) have demonstrated that addition of thrombolytic agents to the initial perfusate enhances the function of transplanted organs (26, 27) . Since in vivo perfusion for DCD is typically performed after prolonged durations of untreated CA, we hypothesized that a similar strategy would be effective in ECPR. We tested this hypothesis in a newly developed porcine model of prolonged untreated CA followed by resuscitation using ECPR.
METHODS
All animals were treated in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guideline for the Care of Use of Laboratory Animals" published by the National Institutes of Health (28) . This study was approved by the University Committee on Use and Care of Animals at the University of Michigan.
Animal Preparation
Fifteen pigs (44 ± 5 kg body weight) were used for this experiment. Animals were sedated with 5 mg/kg tiletamine and zolazepam and 3 mg/kg xylazine given intramuscularly, and anesthesia was induced with inhaled isoflurane (4.0%). Endotracheal intubation was performed and mechanical ventilation instituted (tidal volume 10 mL/kg, respiratory rate adjusted to maintain a Paco 2 of 40 ± 5 torr [5 ± 1 kPa], Fio 2 adjusted to maintain Pao 2 of 150 ± 50 torr (20 ± 7 kPa), and positive endexpiratory pressure 5 cm H 2 o). Anesthesia was maintained with inhaled isoflurane 1.0-3.0%. Core temperature was maintained at 37.5°C ± 0.5°C in the prearrest period. An initial 1,000-mL bolus of normal saline was given IV, followed by continuous infusion of 200-500 mL/hr to replace fluid loss. The animals did not receive any heparin prior to CA.
Hemodynamic Monitoring. Lead II electrocardiography was continuously recorded. The right supraclavicular neck region was dissected and a subclavian arterial catheter was placed to monitor arterial blood pressure (Marquette Electronics, Milwaukee, WI). A pulmonary artery catheter was inserted via the right cephalic vein. Core temperature, mixed venous oxygen saturation (S v o 2 ), and cardiac output (thermodilution technique) were monitored using a Vigilance monitor (Edwards LifeSciences LLC, Irvine, CA). A transvenous right ventricular pacing wire was placed for induction of ventricular fibrillation (VF). A Foley catheter was placed into the bladder for quantification of urine output.
Blood gases, lactate concentration, and activated coagulation time (ACT) were repeatedly measured in arterial blood samples (ABL 725; Radiometer, Copenhagen, Denmark, and Hemochron Blood Coagulation System; International Technidyne Corp., Edison, NJ).
Brain Monitoring and Analysis. For carotid arterial blood sampling, a 5F catheter was introduced into the right carotid artery through small arteriotomy with maintenance of distal flow. For intracerebral monitoring, bilateral burr holes were drilled into the skull. A brain oxygen tension/temperature probe (Licox; Integra, Plainsboro, NJ) and an intracranial pressure (ICP) catheter (Codman & Shurtleff, Raynham, MA) were inserted. ICP, cerebral perfusion pressure (CerPP = mean arterial pressure [MAP] -ICP), and brain tissue oxygen partial pressure (Pbro 2 ) were continuously monitored.
Cortical electroencephalogram (EEG) activity was continuously recorded using eight corkscrew scalp electrodes in a swine montage (29) , labeled analogously to a human 10-20 montage (Natus, San Carlos, CA). EEG was sampled at 256 Hz and then analyzed using Magic Marker software (Persyst Corporation, San Diego, CA). The following values were quantified for all recorded EEG: amplitude-integrated EEG (30), alpha-delta ratio (2-min windows) (31), sd of EEG amplitude (10-s windows), spectral power integrated over 0-4, 4-8, 8-13, and 14-32 Hz (2-s windows), and two commercial algorithms (artifact probability and burst suppression ratio; Persyst Corporation). The sliding 2-minute mean and sd of each value were calculated from baseline and through the entire procedure. Periods of high likelihood for artifact were redacted. Post-CA measurements were normalized to the baseline values. The EEG analysis compared the values of each measurement with baseline (standard two-sample pooled t test) and assessed for any temporal trends that might indicate subtle improvement (Spearman correlation).
Surgical Exposure for ECPR Vascular Access. Prior to initiation of CA, surgical cutdowns were performed on the groin to expose the femoral artery and vein and on the left-side supraclavicular region to expose the subclavian vein in preparation for ECPR cannulation.
CA and ECPR Initiation
A schematic diagram of the experiment design is provided in Figure 1 . After instrumentation was completed and baseline data were collected, VF was electrically induced by delivering a 9 V DC current through the ventricular pacing wire. VF was confirmed by electrocardiogram and arterial pressure tracing. Anesthesia and mechanical ventilation were discontinued. Normothermic no-flow CA was maintained for 30 minutes with no CPR. Figure 2 is a schematic diagram of the ECPR circuit. Vascular access for ECPR was performed during CA. The previously exposed femoral artery and vein were cannulated using 18F-20F venous cannula for blood drainage and a 14F-16F arterial cannula for blood reinfusion. In 13 animals, an additional 16F-18F venous drainage cannula was placed in the left subclavian vein to optimize venous drainage. Cannulas were secured and flushed with heparinized saline while awaiting initiation of ECPR. The ECPR system included a roller peristaltic pump (M-Pump; MC3, Ann Arbor, MI), a commercially available membrane oxygenator, 3/8-inch tubing, and connectors. The system was primed with normal saline 500 mL, sodium bicarbonate 100 mEq, sodium heparin 8,000 IU, vasopressin 20 IU, mannitol 12.5 g, and methylprednisolone 500 mg. Animals were allocated into two experimental groups: thrombolytic-ECPR (t-ECPR), which received streptokinase 1.0 million units added to the pump prime, and control-ECPR (c-ECPR), which did not receive streptokinase. After 30 minutes of untreated CA, the ECPR circuit was turned on to restore systemic circulation. Sodium heparin infusion was started immediately after initiation of ECPR and titrated to keep an ACT of 250-350 seconds.
Resuscitation Protocol
Initial reperfusion with ECPR was performed using a postconditioning perfusion strategy, which is comprised of five cycles of interrupted flow (40 s on and 20 s off for 5 min) as described by Segal et al (32) . After the first 5 minutes of intermittent flow, continuous cardiopulmonary support was established with an ECPR blood flow greater than 50 mL/kg/min. Sweep gas to the oxygenator consisted of a mixture of oxygen and air allowing titration of Fio 2 . ECPR was adjusted to achieve preset Figure 1 . Schematic diagram of extracorporeal cardiopulmonary resuscitation (ECPR) study protocol. After 30 min of untreated ventricular fibrillation (VF) cardiac arrest, animals in both the experimental groups undergo the same 6-hr resuscitation protocol that included ECPR support with preset physiologic targets ("therapeutic targets") for perfusion pressures, blood gases, temperature, and anticoagulation; defibrillation attempts 30 min after ECPR start; and ECPR weaning trial during the last hour of the experiment. Outcome evaluation focused on cardiovascular and cerebral recovery. Animals in thrombolytic-ECPR (t-ECPR) group received streptokinase 1.0 million units at ECPR initiation, whereas animals in control-ECPR (c-ECPR) group did not receive streptokinase. ACT = activated coagulation time, EEG = electroencephalogram, ICP = intracranial pressure, MAP = mean arterial pressure, Pbro 2 = brain tissue oxygen partial pressure, ROSB = return of spontaneous heart beat, STK = streptokinase. physiologic targets: MAP greater than 70 mm Hg (33), CerPP greater than 50 mm Hg (34), Pao 2 150 ± 50 torr (20 ± 7 kPa) (35, 36) , and temperature-corrected Paco 2 40 ± 5 torr (5 ± 1 kPa) (33) in the carotid artery. Active cooling was started using ice packs in order to induce therapeutic hypothermia with a target temperature between 33°C ± 1°C. Surface cooling was chosen rather than a heat exchanger in the ECPR circuit to simplify the ECPR system for these experiments. ECPR support and the physiologic targets were maintained for 5 hours in all the animals.
After 30 minutes of ECPR support, external electrical defibrillation was attempted using up to four shocks at 150-200 J with a biphasic defibrillator (Philips Medical System, Andover, MA). If electrical shock was unsuccessful and VF persisted, repeat defibrillation was attempted after 60 and 120 minutes of ECPR. If VF recurred after initial successful defibrillation, up to three defibrillation attempts (200 J) were performed for each episode of VF. Vasopressin infusion was used if needed to achieve target perfusion pressures. Dobutamine was used for inotropic support during ECPR weaning. If return of spontaneous heart beat (ROSB) occurred, mechanical ventilation was resumed and Fio 2 and minute ventilation adjusted to maintain Pao 2 and Paco 2 targets. After 5 hours of controlled perfusion, weaning from ECPR was attempted in animals with ROSB.
Six hours after initiation of ECPR, animals were euthanized by IV injection of pentobarbital sodium. Immediately upon euthanasia, brain was fixed by bilateral carotid perfusion with 1 L of heparinized saline (10 IU/mL) followed by 1 L of 4% formalin flush. Brain was postfixed in 10% formalin until the time of processing for gross and histopathologic examination.
Outcome Evaluation
Cardiovascular Recovery. Cardiac resuscitability was assessed on the basis of success of defibrillation, ROSB, weanability from ECPR, and left ventricular systolic function (LVSF) after weaning. These components were summarized into a "cardiac resuscitability score" ( Table 1) .
Successful defibrillation was defined as restoration of a stable supraventricular cardiac rhythm.
ROSB was defined as sustained evidence of organized ventricular contractions based on transthoracic echocardiography (TTE). A TTE was performed prior to arrest, after return of stable supraventricular rhythm, and then every hour during ECPR. In the animals with ROSB, weanability from ECPR was assessed during the last hour of the experiment. ECPR blood flow was progressively decreased while titrating vasopressor support. Weaning was determined successful if a stable MAP greater than 65 mm Hg could be maintained with no ECPR flow.
In the animals successfully weaned from ECPR, a final standardized TTE was recorded for a semiquantitative assessment of global left ventricular function (left ventricular shortening fraction and LVSF). Parasternal short-axis views were obtained, video clips recorded, and files uploaded for review by two pediatric cardiologists, who were blinded to the treatment group. For each animal, baseline (prearrest) and final (post-ECPR) clips were graded both qualitatively and quantitatively. Qualitative assessment included grading global LVSF as normal or mildly, moderately, or severely diminished. Quantitative assessment included measuring percentage of fractional shortening whenever degree of systolic function and standardized views permitted accurate assessment.
Arterial Blood Samples. Blood was collected from the carotid arterial catheter prior to CA, 10 minutes after ECPR initiation, 30 minutes after ECPR initiation, and then every hour until the end of the experiment. Measured parameters included pH, Pao 2 , Paco 2 , hemoglobin, arterial lactate, electrolytes, and ACT.
Six-hour lactate clearance was calculated as: six-hour lactate clearance = (peak lactate concentration -final lactate concentration) / peak lactate concentration × 100.
Cerebral Recovery. Assessment of cerebral recovery was based on changes in ICP and Pbro 2 after CA and during ECPR; return of brain electrical activity on EEG; quantification of brain hemorrhages; and acute ischemic neurodegeneration. Continuously recorded EEG was reviewed by a board-certified epileptologist, blinded to study group, to assess whether any significant brain activity had returned. Formalin-fixed brain was cut into 5-mm serial coronal sections and imaged for assessment of intracerebral hemorrhage. Total section area and hemorrhagic area were . Schematic diagram of porcine extracorporeal cardiopulmonary resuscitation (ECPR) model. Anesthetized animals were intubated and connected to a mechanical ventilator. Animal instrumentation included arterial catheter for continuous blood pressure monitoring; carotid and jugular sampling catheters for blood collection; a brain oxygen tension/ temperature probe (Licox probe) and an intracranial pressure (ICP) catheter (ICP probe) for intracerebral monitoring; and scalp electrodes to record cortical electroencefalographic activity. ECPR was performed using a venoarterial (V-A) extracorporeal circuit, with blood drainage from femoral and subclavian vein and blood reinfusion into the femoral artery. The circuit included drainage and reinfusion cannulas, a roller peristaltic pump, an oxygenator, tubing, and connectors. quantified using the Image-Pro Premier software (Media Cybernetics, Inc. Rockville, MD), and the relative area with hemorrhage calculated as percentage of total area imaged.
Brain was then processed for paraffin histology using standardized dissections of selectively vulnerable brain regions (dorsal hippocampus, cerebellar vermis, caudal putamen, parietal cortex, and thalamus) to ischemia. Acute neuronal degeneration was scored on 0-5 scale (0 = 0% neuronal injury, 1 = 1-20%, 2 = 21-40%, 3 = 41-60%, 4 = 61-80%, and 5 = 81-100%) by estimating the percentage of neurons showing ischemic cytopathology in each region.
Statistical Analysis
All parameters were tested for normality using the Shapiro-Wilk test. Continuous variables with a normal distribution are expressed as mean ± sd and compared using Student t test. Continuous variables without a normal distribution are expressed as median and interquartile range and compared using Mann-Whitney U test. For repeated measurements, twoway analysis of variance was used to detect intergroup differences and corrected with the Bonferroni method for multiple comparisons. Categorical variables are compared using Fisher exact test. p values less than 0.05 were considered significant.
RESULTS
Out of 15 animals entered in the study, 2 animals were excluded from data analysis due to technical difficulties with venous access resulting in ECPR blood flow less than 50 mL/kg/min. In 13 animals (n = 7 in t-ECPR group; n = 6 in c-ECPR group), ECPR was successfully initiated 30 minutes after VF induction. Baseline characteristics were similar between the two groups ( Table 2) .
Physiologic Parameters of Reperfusion
Predetermined physiologic targets were achieved within the first 30 minutes of ECPR ( Table 3 ) and maintained throughout the study in both groups (Fig. 3, A-D) . Time to achieve target temperature for therapeutic hypothermia was 69 ± 23 minutes in t-ECPR and 70 ± 25 minutes in c-ECPR (p = 0.95). ACT was maintained in the therapeutic range in both groups (290 ± 55 s in t-ECPR and 310 ± 71 s in c-ECPR, p = 0.59), and the required dose of heparin did not differ between groups (1,353 ± 304 U/hr in t-ECPR and 1,163 ± 221 U/hr in c-ECPR; p = 0.26). Average vasopressin dose over the duration of the experiment was similar between groups (0.37 ± 0.20 U/min in t-ECPR and 0.4 ± 0.2 U/min in c-ECPR; p = 0.67).
Cardiovascular Recovery
Cardiac resuscitability for the two groups is summarized in Figure 4 . All the animals in t-ECPR (seven of seven) and three of six animals in c-ECPR group could be defibrillated into stable supraventricular rhythm. Defibrillation success rate was not statistically different between the two groups (p = 0.07). ROSB occurred in seven of seven (100%) animals in t-ECPR group and in one of six (17%) animals in c-ECPR group (p < 0.01). Four of seven animals (57%) in t-ECPR group and one of six (17%) animals in c-ECPR were successfully weaned from ECPR (p = 0.27). After weaning, LVSF was moderately diminished in the four animals in t-ECPR and severely diminished in the animal in c-ECPR group. Cardiac resuscitability score was 3.7 ± 1.6 in t-ECPR group and 1.0 ± 1.5 in c-ECPR group (p < 0.05) using Mann-Whitney U test ( Table 4) .
Arterial Blood Samples and Urine Output
Arterial lactate concentration markedly increased after CA. t-ECPR group had significantly lower lactate concentration at the peak level (11.6 ± 0.7 vs 12.6 ± 0.6; p < 0.05) at 3 and 4 hours (Fig. 3G) . Six-hour lactate clearance was significantly higher in t-ECPR than in c-ECPR (40% ± 15% vs 18% ± 21%; p < 0.05).
Hemoglobin concentration at 6 hours was not significantly different between groups (8.0 ± 1.5 in t-ECPR and 8.5 ± 2.2 in c-ECPR; p = 0.63). During ECPR, urine output was restored in both groups.
Cerebral Recovery
After 5 hours of ECPR, before starting weaning attempts, ICP was significantly increased from baseline in the c-ECPR (34 ± 16 mm Hg; p < 0.01) but not in the t-ECPR group (16 ± 3 mm Hg; p = 0.37). The absolute increase in ICP was 19 ± 13 mm Hg in c-ECPR and 1 ± 3 mm Hg in t-ECPR groups (p < 0.05). Comparing ICP between the two groups, values were significantly higher in c-ECPR group than in t-ECPR group at 6 hours (Fig. 3E) . As expected, brain oxygen tension (Pbro 2 ) dropped during CA in both groups (0.7 ± 0.5 torr [0.1 ± 0.06 kPa] in t-ECPR, 0.9 ± 0.4 torr [0.12 ± 0.05] in c-ECPR; p = 0.64). ECPR initiation was followed by a rise in Pbro 2 in both groups. No significant difference in Pbro 2 values between the groups was observed throughout the experiment (Fig. 3F) . Quantitative analysis of EEG signal revealed no recovery of brain activity in either group. Burst suppression ratio remained unchanged or worse, and the EEG power was unchanged in all spectral bands ( Table 5 ). Both groups had some evidence of intracerebral hemorrhages at pathologic examination. The extent of hemorrhagic areas as a percentage of the entire brain was significantly larger in c-ECPR than in t-ECPR groups (1.1% ± 0.7% vs 0.2% ± 0.2%; p < 0.05) ( Fig. 5 and Supplemental Fig. 1 , Supplemental Digital Content 1, http://links. lww.com/CCM/B437). The overall histopathologic neurodegeneration score was not different between groups (3.2 ± 1.1 in t-ECPR and 3.2 ± 0.9 in c-ECPR; p = 0.97). The regional neurodegeneration scores are presented in Figure 6 .
DISCUSSION
This study tested the hypothesis that thrombolytic-enhanced ECPR improves resuscitation and organ function recovery after prolonged CA. Our results demonstrate that adding a thrombolytic agent to the ECPR initial perfusate improves cardiac resuscitability while reducing brain edema. These effects were observed without significant bleeding complications. However, we were unable to detect an early effect on EEG recovery or ischemic neuronal injury.
Intravascular Coagulation After Prolonged CA
It has long been known that prolonged CA is associated with a marked activation of blood coagulation (18, 24, 37) . Crowell et al (24) originally described intravascular coagulation during CA in the 1950s. In these early studies, Crowell et al (24) also demonstrated that pretreatment with IV heparin resulted in a dosedependent improvement in CA survival. More recently, White et al (22) using whole thromboelastography observed that clot initiation time (R) was shortened and clot strength (maximum amplitude) tended to increase at 8 minutes of untreated VF.
One study suggests that a diffuse endothelial damage may occur after CA (19) and the subsequent exposition of tissue factor is likely to be an important contributing mechanism to the postarrest prothrombotic state (21) . Budhram et al (17) (23) reported echocardiographic detection of intracardiac thrombus at 20-30 minutes after CA onset, a finding that was uniformly associated with failed resuscitation. ECPR after OHCA is typically initiated 30-60 minutes after CA onset, making the likelihood of intravascular coagulation high in these patients. Intravascular coagulation could represent a limiting factor to restoring tissue perfusion after ischemia, creating a "noreflow" phenomenon in which there is an absence of microvascular flow despite return of circulation (19, 38, 39) . The role of intravascular coagulation in the pathogenesis of reperfusion disturbances after CA is supported by the observations that prearrest administration of heparin or streptokinase improves survival and neurologic outcome (24, 37, 40) . Furthermore, Fischer et al (25) demonstrated that the no-reflow phenomenon in the brain is reduced by thrombolytic administration during standard CPR after prolonged CA. The severity and extent of brain no-reflow increase with the duration of untreated CA (19) . The secondary injury caused by no-reflow appears to become relevant after durations of untreated CA longer than 12-15 minutes (41) . With ECPR return of circulation is achieved after periods of CA long enough to allow for intravascular coagulation causing the no-reflow phenomenon and thus the potential for improving reperfusion could be maximized with thrombolytic agents. Streptokinase preflush during ex situ and in situ perfusion of kidneys from DCD has been shown to improve the function of transplanted organs after up to 60 minutes of asystole (26, 27) . Organs transplanted after in situ perfusion during DCD procurement undergo the same pathophysiologic events of ischemia-reperfusion as organs resuscitated after prolonged CA, including the possible occurrence of no-reflow phenomenon. Therefore, it is conceivable that, similar to its effects in DCD, thrombolytic therapy can improve functional organ recovery after prolonged CA.
Optimizing Initial Reperfusion With ECPR
The quality of early reperfusion affects organ function recovery after prolonged ischemia (34, 35, 42, 43) . Effective control of reperfusion conditions (including MAP, Pao 2 , Paco 2 , and temperature) is one of the mechanisms proposed to explain the superiority of ECPR over CPR (42, 44) . In developing this model, we adopted the current state of literature in terms of optimization of initial reperfusion after CA. The levels of MAP that we maintained (70-90 mm Hg) are in line with the recommendations of the International Liaison Committee on Resuscitation (33). Allen et al (34) reported that a CerPP of 50 mm Hg is needed to minimize brain injury after 30 minutes of global brain ischemia in swine. Vasopressin was chosen as the vasopressor agent because experimental studies in pigs have demonstrated beneficial effects in the improvement of vital organ blood flow (45) and cerebral microcirculation (46) after CA. The target for Pao 2 (150 ± 50 torr [20 ± 7 kPa]) was selected to provide adequate oxygen delivery, while limiting the potential detrimental effects of hyperoxia during early reperfusion (35, 36) . Of note, strict control of Pao 2 becomes more challenging after ROSB because repeated adjustments of both ECPR and ventilator settings are required when native cardiac output is restored. This difficulty explains the slight difference in Pao 2 between the two groups at 3 and 4 hours. Paco 2 was maintained within the normal range in order to avoid secondary ischemia caused by cerebral vasoconstriction and increased ICP caused by cerebral vasodilation. Mild therapeutic hypothermia was applied according to current guidelines (33) , with target temperature of 33°C ± 1°C attained within 2 hours of initiating ECPR.
Cardiovascular Recovery With t-ECPR
Our results indicate that thrombolytic-enhanced ECPR increases cardiac resuscitability. During VF, the effectiveness of defibrillation diminishes over time. Optimization of myocardial perfusion is required to restore myocardial conditions favorable for successful defibrillation (47) . The rate of successful defibrillation in the c-ECPR group (50%) corresponds to . Cardiac resuscitability outcomes. Defibrillation success was defined as return of stable supraventricular rhythm. Return of spontaneous heart beating (ROSB) was assessed on the basis of the evidence of heart contraction by qualitative echocardiography. Weaning from extracorporeal cardiopulmonary resuscitation (ECPR) was determined successful if a stable mean arterial pressure greater than 65 mm Hg could be maintained with no ECPR flow. Semiquantitative assessment of left ventricular (LV) function after weaning was performed by two blinded echocardiographers using standardized echocardiographic view. All the animals in thrombolytic-ECPR (t-ECPR) group (seven of seven) could be successfully defibrillated into stable supraventricular rhythm. In the control-ECPR (c-ECPR) group, three of six animals (50%) achieved restoration of stable supraventricular rhythm; in two of them defibrillation was successful at 30 min after ECPR initiation, whereas one had persistent refractory ventricular fibrillation and was successfully defibrillated after IV administration of amiodarone 150 mg. Of the remaining three animals in c-ECPR group, one had recurrent VF with supraventricular rhythm restored only transiently despite repeat defibrillation attempts and two had degeneration into asystole (see Table 4 for calculation of cardiac resuscitability score). what reported in an early dog study with the same duration of CA followed by ECPR (14) . Early decline of heart function after resuscitation is associated with a parallel impairment of myocardial microcirculation (48) . In line with our findings, an earlier study by Fischer et al (25) has demonstrated that thrombolytics improve recovery of cardiac contractility after prolonged (15 min) CA and standard CPR. Better lactate clearance also indicates improved reperfusion with the use of thrombolytics. The higher lactate concentrations and the lower lactate clearance in the c-ECPR group suggest a greater persistence of anaerobic metabolism and thus inadequate organ perfusion without the use of thrombolytics.
Cerebral Recovery With t-ECPR
In our study, thrombolytic-enhanced ECPR prevents the progressive rise in ICP, which is likely to occur during the early reperfusion after prolonged CA. ICP changes after CA have not been widely investigated. Snyder et al (49) reported no significant rise Quantitative electroencephalogram (EEG) analysis compared the effect of thrombolytic-extracorporeal cardiopulmonary resuscitation (t-ECPR) with that of control-extracorporeal cardiopulmonary resuscitation (c-ECPR). During cardiac arrest (CA), EEG signals changed drastically, which was quantified with several different measurements taken every 10 s. After return of spontaneous heart beat (ROSB), these measurements did not improve in either group. a The only value trending toward significance was the Spearman correlation of Alpha/Delta ratio, which as a two-tailed test needed p < 0.025 to be significant. The last four columns represent spectral band power of indicated frequency ranges. T stat = raw statistic from the two-sample t test, comparing the distribution of each measurement during CA vs after ROSB, Spearman = Spearman correlation of each measurement after ROSB vs time. Figure 5 . Brain hemorrhage quantification. Brain hemorrhages were measured on serial brain slices using Image-Pro Premier software and expressed in percentage of the area imaged for the entire brain. The results presented as mean ± sd of percentage. Mann-Whitney unpaired t test was using to compare groups. Statistical significance was set at p < 0.05. c-ECPR = control-extracorporeal cardiopulmonary resuscitation, t-ECPR = thrombolytic-extracorporeal cardiopulmonary resuscitation.
Critical Care Medicine www.ccmjournal.org e67 in ICP after 15 minutes of global ischemia in dogs, but marked cerebral edema develops after 30 minutes of global brain ischemia followed by uncontrolled reperfusion in pigs (50) . The progressive rise in ICP with c-ECPR is therefore likely caused by persistent or progressive multifocal brain ischemia, resulting in increasing cerebral edema.
Considering the relatively short duration of observation, the absence of recovery of brain electrical activity on EEG in either group is not unexpected and does not exclude the potential for recovery of function with longer postarrest observation times (51) .
Surprisingly, the rise in ICP in the c-ECPR group was not associated with more severe ischemic neurodegeneration based on early histologic examination. Since cytotoxic brain edema represents the initial step in the progression of ischemic neuronal injury, it is conceivable that the histopathologic changes were still developing at the time of brain harvesting. Indeed, delayed onset and progression of neurodegeneration up to 72 hours after the ischemic insult have been reported in experimental models of transient global cerebral ischemia (52) . An alternative hypothesis is that the beneficial effect of thrombolytic therapy on ICP was mediated through effects on non-neuronal cells including the brain endothelium and/or glial cells. Improvement of early reperfusion is likely to be only one component of a complex strategy to prevent neuronal injury after prolonged CA. In experimental studies of isolated global brain ischemia, Allen et al (34) demonstrated that controlled reperfusion provides complete neurologic recovery after 30 minutes of warm ischemia. Nevertheless, models of isolated organ ischemia fail to fully reproduce the pathophysiology of CA: secondary brain injury after resuscitation may result from the consequences of whole-body ischemia, which include cardiac and respiratory dysfunction with impairment of systemic perfusion and oxygenation and systemic release of inflammatory mediators.
Complications of t-ECPR
Reported incidence of major hemorrhagic complications during ECPR ranges from 14% (8) to 29% (15) . Risk of bleeding is the major drawback of the use of thrombolytics after CA, and it is potentially magnified by the systemic anticoagulation Figure 6. Regional histopathology and neurodegeneration scores. Neuronal damage in selectively vulnerable brain regions was quantified in 5-μm sections stained with hematoxylin and eosin (H&E). Each region was divided into nine ×40 fields using a standardized method. Within each field, the region with the most neuron damage was imaged. For each animal, an average score of neurodegeneration from the nine fields was obtained for each region. Morphologic criteria for acute ischemic neurodegeneration included cytoplasmic eosinophilia, neuronal cell body shrinkage and angulation, and nuclear pyknosis. A, Brain histopathology of three representative animals from the studies was shown at five specific brain regions that stained with H&E and imaged at ×40 magnification. The acute ischemic degenerating neurons (pyknosis of nucleus, shrinkage and angulation cell body, and eosinophilia of cytoplasm) were seen at all regions in the two groups. Neurons in the sham animal represent normal histologic appearance. B, Regional neurodegeneration scores. Severity of acute neurodegeneration was quantified using 0-5 scale in five brain regions and an overall score was calculated (see Methods). The results presented as mean ± sd of the scores for individual brain regions [parietal cortex (PC), hippocampal CA1 sector (CA1-Hip). caudoputamen (CPut), thalamus (TH), cerebellar vermis (CbV), and all regions combined (All). One-way analysis of variance was used, followed by Tukey multiple comparisons test. p < 0.05 was considered statistically significant. There was no significant difference between the two groups at each individual region. c-ECPR = control-extracorporeal cardiopulmonary resuscitation, t-ECPR = thrombolytic-extracorporeal cardiopulmonary resuscitation. required for ECPR. However, thrombolytic therapy was not associated with increased bleeding complications in this study. Conversely, the average extent of brain hemorrhages was significantly smaller in t-ECPR group. This seemingly paradoxical result might be explained by the effectiveness of thrombolytic therapy in reducing ischemic injury. Extensive brain infarctions have been reported in porcine models of 30-minute global brain ischemia and reperfusion (34) , and hemorrhagic conversion of ischemic infarctions is potentially facilitated by heparinization during ECPR. By decreasing the number or size of ischemic infarctions, thrombolytic therapy may result in a lower overall incidence of intracerebral hemorrhage. Importantly, both the choice of lytic agent and the mode of administration may affect the risk of hemorrhagic adverse effect. The in vivo half-life of streptokinase is 30 minutes; therefore, single bolus administration results in a relatively short-term activation of fibrinolysis, which may mitigate the risk of bleeding.
Study Limitations
The relatively short period of observation after CA limits the assessment of long-term recovery of organ function in this experimental study. A 30-minute period of untreated CA followed by ECPR is unlikely to occur in the clinical setting where standard CPR is likely to precede ECPR. The rational for using this study design was to more efficiently test the hypothesis that thrombolytics improve functional recovery of vital organs after prolonged CA. Adding CPR to the model would have created significant variability, thus affecting the possibility to discern the impact of thrombolytic therapy. We acknowledge that different combinations of no-flow and low-flow time, together with the quality of CPR, will have an impact on the underlying pathophysiology of intravascular coagulation, and the effectiveness of treatments intended to improve early organ reperfusion.
Another limitation of our approach is that we did not quantify the extent of intravascular coagulation in the organs of the experimental animals. We instead elected to examine the clinically relevant outcomes of functional organ recovery. Therefore, we do not have a direct evidence to demonstrate that the differences in outcome between the two groups were caused by reversal of intravascular coagulation. Direct measurements of intravascular coagulation in future studies using more mechanistically oriented models are needed. These studies will be essential to characterize the time course and location of intravascular coagulation during prolonged CA, identify the most effective and safe thrombolytic agents, and optimize the dose and duration of thrombolytic therapy.
Finally, the evaluation of cerebral resuscitation was based on physiologic surrogates (ICP and Pbro 2 ), EEG, and histology, with a relatively short recovery period of 6 hours. The relationship between these measurements and ultimate recovery of neurologic function remains to be determined in this experimental model. We do expect that a period of at least 7 days will be needed reliably assess ultimate recovery of neurologic function. Long-term outcome studies will be essential to demonstrate the impact of thrombolytic-enhanced ECPR on survival with good neurologic function.
CONCLUSIONS
The combination of ECPR and thrombolytic therapy after prolonged untreated CA improves recovery of cardiac function and reduces brain edema without increasing bleeding complications. However, we were unable to detect an effect on early EEG recovery or ischemic neuronal injury. Longerterm outcome studies will be needed to fully elucidate the impact of thrombolytic-enhanced ECPR on cardiovascular and cerebral recovery.
